Inj Nivolumab 240mg, Inj Bevacizumab 800 mg, Tab Darolutamide 600mg, inj Cycloprophamide 500mg plus 250ml NS
Indian Army · Gaya, Bihar · Pharmaceuticals · open
Key facts
- EMD: ₹5K
- Published: 19 Aug 2026
- Closing date: 29 Aug 2026
- Status: open
- Ministry: Ministry of Defence
- Department: Department of Military Affairs
Description
Tender for procurement of specified biological and pharmaceutical products including Nivolumab, Bevacizumab, Darolutamide, and Cycloprophamide with a total quantity of 337 units, under the Department of Military Affairs, Indian Army, Ministry of Defence. Bid validity is 120 days from the end date, with detailed technical specifications and delivery schedule. EMD and ePBG details provided, along with MSE and Make in India preferences.
Eligibility & requirements
- Startup relaxation: No
- MSE relaxation: Yes
- Documents required: OEM Authorization Certificate, BoQ compliance documents
New to these terms? Read how tender eligibility criteria work.
Commercial terms
- Bid type: Two Packet Bid
- Evaluation: item wise evaluation
- Make in India (MII): Yes
- MSE preference: Yes
Line items (4)
- Nivolumab 240mg — Qty: 337 Inj
- Bevacizumab 800 mg — Qty: 337 Inj
- Darolutamide 600mg — Qty: 337 Tab
- Cycloprophamide 500mg plus 250ml NS — Qty: 337 inj
1 tender document(s) available — sign up to download.
Related tenders
- Torsemide 10 mg — Pharmaceuticals
- Bilastine 20 mg — Pharmaceuticals
- Paclitaxel 260 mg Injection — Pharmaceuticals · Madhya Pradesh
- TAB/CAP TEMOZOLAMIDE 100 MG. — Pharmaceuticals · Madhya Pradesh · ₹8.0L
- Megesterol 160 mg TABLETS — Pharmaceuticals · ₹10.0L
- Running Contract for Tab/Cap Azelnidipine 16 mg in strip packing. — Pharmaceuticals
- Running Contract for Sodium Chloride 3%, 100 ml Glass Bottle. — Pharmaceuticals
- Running Contract for Salbutamol 2.5 mg /2.5 ml Nebulising Solution 2.5 ml Respule/Amp. — Pharmaceuticals